series-a
Stage
2017
Founded
1
Investors
About
BCI Pharma is a clinical-stage biotechnology company developing innovative small molecule therapies for severe inflammatory diseases, particularly those affecting the central nervous system. Their lead program targets the NLRP3 inflammasome pathway.
Explore BCI Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.